RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 121 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $44,000 | +4.8% | 37,550 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $42,000 | -90.2% | 37,550 | -73.8% | 0.00% | -89.3% |
Q1 2022 | $429,000 | +725.0% | 143,592 | +845.3% | 0.03% | +64.7% |
Q1 2021 | $52,000 | -69.8% | 15,190 | -79.0% | 0.02% | -65.3% |
Q4 2016 | $172,000 | -86.0% | 72,249 | -78.3% | 0.05% | -86.2% |
Q3 2016 | $1,225,000 | +121.9% | 333,657 | +34.9% | 0.35% | +58.0% |
Q2 2016 | $552,000 | +101.5% | 247,340 | +87.5% | 0.22% | +117.5% |
Q1 2016 | $274,000 | +64.1% | 131,889 | +140.0% | 0.10% | +32.1% |
Q4 2015 | $167,000 | +22.8% | 54,960 | 0.0% | 0.08% | +4.0% |
Q3 2015 | $136,000 | -22.7% | 54,960 | 0.0% | 0.08% | -22.7% |
Q2 2015 | $176,000 | -10.2% | 54,960 | 0.0% | 0.10% | -11.0% |
Q1 2015 | $196,000 | +553.3% | 54,960 | +318.9% | 0.11% | +505.6% |
Q4 2014 | $30,000 | +20.0% | 13,120 | 0.0% | 0.02% | -5.3% |
Q3 2014 | $25,000 | -47.9% | 13,120 | 0.0% | 0.02% | -38.7% |
Q2 2014 | $48,000 | – | 13,120 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |